FDA Approves Vibegron for Men With Overactive Bladder Symptoms Receiving Therapy for ...
FDA approved vibegron (Gemtesa) for men with OAB symptoms on BPH therapy, showing improvements in OAB symptoms in phase 3 trials. It's the first β3 agonist for this group, addressing a prevalent, often undiagnosed condition.
Related News
FDA Approves Vibegron for Men With Overactive Bladder Symptoms Receiving Therapy for ...
FDA approved vibegron (Gemtesa) for men with OAB symptoms on BPH therapy, showing improvements in OAB symptoms in phase 3 trials. It's the first β3 agonist for this group, addressing a prevalent, often undiagnosed condition.